Clik here to view.
Abbott touts data from rotor-ablation AF trial
Abbott (NYSE:ABT) today announced results from 3 clinical studies of focal impulse rotor modulation guided rotor ablation for treating atrial fibrillation using the company’s RhythmView technology,...
View ArticleClik here to view.
Variation in Medicine: What Would Darwin Say?
By Amy Siegel, S2N Health Some of S2N’s recent work has gotten me thinking about variation, sometimes extreme, in the practice of seemingly routine medical care. Take the interventional treatment of...
View ArticleClik here to view.
Study: Metal-on-metal hips impede osteoblast formation
A study of metal-on-metal hip implants found that the metal ions released when the parts of the cobalt-chromium-molybdenum devices rub against each other were able to penetrate into bone marrow, where...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for June 22, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Trial starts for Energex founder accused in $230k embezzlement case
The trial against former Energex CEO Thomas Fagan got underway this week in the Mercer County Superior Court in New Jersey, according to The Trentonian. Fagan is being charged with 15 criminal counts,...
View ArticleClik here to view.
FDA bans importation of Berwickshire’s Helica thermal coagulator and probes
The FDA today released a warning letter it sent to Berwickshire Electronic Manufacturing detailing issues with the firm’s manufacturing processes and barring the products from importation into the...
View ArticleClik here to view.
NeuroMetrix seeks CE Mark for Quell OTC pain relief device
NeuroMetrix (NSDQ:NURO) said today it is seeking CE Mark approval in the European Union for over-the-counter clearance for its Quell wearable chronic pain relief system. The company touted recent...
View ArticleClik here to view.
Appeals court won’t review J&J’s Ethicon loss in stapler patent spat with...
The U.S. Patent and Trademark Office Patent Trial and Appeal Board today denied a rehearing request after a loss in a spat between Johnson & Johnson (NYSE:JNJ) and Covidien, now owned by Medtronic...
View ArticleClik here to view.
IBM forms medical imaging collaborative with Watson
IBM (NYSE:IBM) said today it formed the Watson Health medical imaging collaborative, which aims to bring cognitive imaging into daily practice for practitioners through a collaborative, global...
View ArticleClik here to view.
Nevro takes a hit after insurers deem Senza therapy experimental
Shares in Nevro (NYSE:NVRO) took a hit yesterday after investors learned that a pair of insurers in Pennsylvania and Tennessee tagged therapy using its Senza spinal cord stimulation device as...
View ArticleClik here to view.
FDA celebrates the 40th anniversary of the Medical Device Amendments
By: Jeffrey Shuren, M.D., J.D. In 1976, Steve Jobs and Steve Wozniak founded Apple and a gallon of gas was $.59. And in another action that has had long term impact, President Ford signed the Medical...
View ArticleClik here to view.
Trial slated in wrongful death suit over Norian XR bone cement
A state court in Washington is slated next week to hear the 1st trial in a group of civil lawsuits filed by the families of patients who died on the operating table minutes after injection with the...
View ArticleClik here to view.
FDA defends response to late Medtronic Infuse data
The FDA reportedly defended its response to the 5-year delay by Medtronic (NYSE:MDT) in reporting results from an internal study of its controversial Infuse bone growth protein, saying it took no...
View ArticleClik here to view.
St. Jude wins CE Mark, launches SyncAV CRT algorithm
St. Jude Medical (NYSE:STJ) said today it won CE Mark approval in the European Union and launched its SyncAV CR software algorithm designed to optimize the company’s MultiPoint pacing technology. The...
View ArticleClik here to view.
HeartFlow launches new FFRct cardiac imaging platform
HeartFlow said today that it’s launching a new version of its cardiac imaging platform, which uses algorithms to generate a 3D model of blood as it flows through the heart. Redwood City, Calif.-based...
View ArticleClik here to view.
GI Dynamics releases final data from EndoBarrier trial
GI Dynamics (ASX:GID) today released the results of the pivotal clinical Endo trial of its EndoBarrier device designed for weight loss, touting meaningful losses in HbA1c and weight, while...
View ArticleClik here to view.
Smells are smart sensors’ last frontier
(Reuters) — Phones or watches may be smart enough to detect sound, light, motion, touch, direction, acceleration and even the weather, but they can’t smell. That’s created a technology bottleneck that...
View ArticleClik here to view.
Denmark’s Ambu pays $16m for ETView Medical
Ambu (CPH:AMBU-B) agreed to pay $16 million to acquire ETView Medical (TLV:TLV) and its portfolio of airway management devices. The deal calls for Copenhagen-based Ambu to put up $12.3 million in cash...
View ArticleClik here to view.
Appeals court upholds Thermomedic win over Exergen
The U.S. Court of Appeals for the Federal Circuit upheld a decision from the lower courts invalidating a series of Exergen’s patents in a spat between Exergen and Thermomedics. The spat is over patents...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for June 23, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View Article